MedTrace Logo

Evaluation of a Medication Disposal Program in Primary Care

NCT04320004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1159

Last updated 2021-09-22

No results posted yet for this study

Summary

Evidence from recent trials primarily in the post-surgical patient population prescribed opioids for acute pain suggest patients more often properly dispose of unused opioids if instructed by a healthcare professional, if provided education on proper storage and disposal, and provided a physical medication disposal product (e.g. mail back bags). It is not clear how this evidence applied to patients in primary care will be readily adopted and sustained by practices and if the effectiveness will be comparable to that seen in other more controlled studies, largely limited to the surgical population. The objective of this trial is to evaluate a multifaceted program for safe medication disposal in primary care. Interventions include real-time best practice reminders to providers, educational materials mailed to patients, disposal mail-back bags supplied to patients and reminder phone calls. Proper medication disposal after 30 days following order will be assessed by telephone survey.

Our aims are to:

1. Evaluate a targeted intervention on patient's newly prescribed opioids within primary care.
2. Determine factors that influence patient action to remove unused opioid medications from the home.

Conditions

  • Opioid-Related Disorders

Interventions

BEHAVIORAL

Education

Subject receives education

BEHAVIORAL

Education with Reminder

Subject receives education with reminder

BEHAVIORAL

Education + Disposal Bag

Subject receives education and disposal bag

BEHAVIORAL

Education + Disposal Bag with Reminder

Subject receives education + disposal bag with reminder

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Eric Wright, PharmD,MPH · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-05-06
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04320004 on ClinicalTrials.gov